Form 4: New Enterprise Associates 17, L.P. Invests in Korro Bio, Inc.

New Enterprise Associates 17, L.P. acquired 17,857 shares of Korro Bio, Inc. common stock at $56 per share on April 22, 2024, and indirectly holds 1,090,793 shares.

Summary

• New Enterprise Associates 17, L.P. (NEA 17) acquired 17,857 shares of Korro Bio, Inc. (KRRO) common stock on April 22, 2024, at a price of $56 per share.
• Following this transaction, NEA 17 directly holds 1,090,793 shares of KRRO common stock.
• The transaction was made pursuant to a Subscription Agreement dated April 17, 2024.
• NEA Partners 17, L.P., NEA 17 GP, LLC, and the individual managers of NEA 17 GP indirectly hold these securities.
• These managers include Forest Baskett, Ali Behbahani, Carmen Chang, Anthony Florence, Jr., Mohamad Makhzoumi, Edward Mathers, Scott Sandell, Paul Walker, and Rick Yang.
• The Indirect Reporting Persons disclaim beneficial ownership of the securities held by NEA 17 in which they have no pecuniary interest.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The filing indicates a continued investment by a major shareholder, which is generally a positive sign. However, it's a routine filing, so the impact is likely moderate.

Positives

• NEA 17's investment in Korro Bio could be seen as a positive signal, indicating confidence in the company's prospects.
• The acquisition increases NEA 17's stake in Korro Bio, demonstrating a continued commitment to the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by significant shareholders, directors, and officers, providing transparency to the market.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder confidence due to the increased investment by NEA 17.

Key Dates